Could a herbal tablet protect kidneys in diabetes?

NCT ID NCT01068041

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a plant-based tablet called PH3 in 100 adults with diabetic nephropathy (kidney damage from diabetes). The goal was to see if PH3 can safely reduce protein in the urine, a sign of kidney stress, over 24 weeks. Researchers also looked at the best dose to use in future studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PH3 (a plant-based tablet)
What this could lead to
If successful, PH3 could offer a new option to slow kidney damage in people with diabetes.
What could go wrong
This is an early Phase 2 trial with only 100 participants. It may not show clear benefit, and the optimal dose is still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taichung Veterans General Hospital

    Taichung, 407, Taiwan

  • Taipei Veterans General Hospital

    Taipei, Taiwan

  • Tri-Service General Hospital

    Taipei, 114, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.